Dr. Mewada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3600 Gaston Ave
Ste 960
Dallas, TX 75246Phone+1 214-820-0111
Summary
- Dr. Nishith Mewada is a pulmonologist in Dallas, TX and is affiliated with Baylor University Medical Center. He received his medical degree from Gujarat University - N.H.L Municipal Medical College in India. He is board certified in Internal Medicine, Pulmonary Medicine, Critical Care Medicine and Neuro-Critical Care
Education & Training
- Tulane UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2017 - 2020
- Capital Health Regional Medical Center/St. Francis Medical CenterResidency, Internal Medicine, 2013 - 2014
- Capital Health Regional Medical Center/St. Francis Medical CenterResidency, Internal Medicine, 2011 - 2014
- N.H.L Municipal Medical CollegeClass of 2009
Certifications & Licensure
- TX State Medical License 2015 - 2026
- MO State Medical License 2021 - 2023
- LA State Medical License 2017 - 2021
- IN State Medical License 2015 - 2019
- NM State Medical License 2014 - 2017
- NJ State Medical License 2012 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 16 citationsStarvation marrow - gelatinous transformation of bone marrow.Eric Osgood, Salman Muddassir, Minal Jaju, Robert Moser, Farwa Farid
Journal of Community Hospital Internal Medicine Perspectives. 2014-09-29 - 2 citationsRole of Therapeutic Plasma Exchange in Treatment of Tumefactive Multiple Sclerosis-Associated Low CD4 and CD8 LevelsKristen Lew, Nishith Mewada, Sahana Ramanujam, Bahareh Hassanzadeh, John E. Donahue
Case Reports in Neurology. 2016-08-31 - 8 citationsA Phase I/II Study of Docetaxel, Oxaliplatin, and Fluorouracil (D-FOX) Chemotherapy in Patients with Untreated Locally Unresectable or Metastatic Adenocarcinoma of the...Mariela A. Blum Murphy, Wei Qiao, Nishith Mewada, Roopma Wadhwa, Elena Elimova
American Journal of Clinical Oncology. 2016-02-22
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: